Amplatzer Occluder Therapy
Patients diagnosed with an atrial septal defect (ASD), who are indicated for closure with an Amplatzer™ Septal Occluder, exhibit both:
- Echocardiographic evidence of ostium secundum ASD
- Clinical evidence of right ventricular (RV) volume overload (i.e., ratio of pulmonary to systemic flow > 1.5 or RV enlargement)
After receiving ASD closure with the Amplatzer™ Septal Occluder, Bao remarks:
“I feel better. And maybe (now) I can have more energy to play with my daughter.”
Patient Experience after Atrial Septal Defect Occlusion
Patients typically report symptom improvement after the closure of the ASD. In young children, growth rate can increase, and in children and young adults, LV filling improves. When younger patients are treated—those who have less chamber enlargement before repair—there is greater likelihood of normalization of RV size.
To learn more about atrial septal defect and to read frequently asked questions by patients, please visit MyAmplatzer.com.
MAT-2008368 v1.0 | Item approved for Global OUS use only.
- Turner DR, Owada CY, Sang II CJ, et al. Closure of secundum atrial septal defects with the Amplatzer Septal Occluder: a prospective, multicenter, post-approval study. Circ Cardiovasc Interv. 2017;10:e004212.